Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review.

Yamakawa, Hideaki; Toyoda, Yuko; Baba, Tomohisa; Kishaba, Tomoo; Fukuda, Taiki; Takemura, Tamiko; Kuwano, Kazuyoshi

Yamakawa, Hideaki; Toyoda, Yuko; Baba, Tomohisa; Kishaba, Tomoo; Fukuda, Taiki; Takemura, Tamiko; Kuwano, Kazuyoshi.

Afiliação

Yamakawa H; Department of Respiratory Medicine, Saitama Red Cross Hospital, 1-5 Shintoshin, Chuo-ku, Saitama 330-8553, Japan.
Toyoda Y; Department of Respiratory Medicine, Tokyo Jikei University Hospital, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan.
Baba T; Department of Internal Medicine, Japanese Red Cross Kochi Hospital, 1-4-63-11 Hadaminamimachi, Kochi 780-8562, Japan.
Kishaba T; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama 236-0051, Japan.
Fukuda T; Department of Respiratory Medicine, Okinawa Chubu Hospital, Okinawa, 81 Miyazato, Uruma 904-2293, Japan.
Takemura T; Department of Radiology, The Jikei University Daisan Hospital, 4-11-1 Izumihoncho Komae-shi, Tokyo 201-8601, Japan.
Kuwano K; Department of Pathology, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama 236-0051, Japan.

J Clin Med ; 11(13)2022 Jul 01.

Article em En | MEDLINE | ID: mdl-35807120

Palavras-chave

interstitial lung disease; microscopic polyangiitis; myeloperoxidase antineutrophil cytoplasmic antibody; therapeutic option

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Clin Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google